GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN THE REAL WORLD: ARE CLINICAL TRIALS REPRODUCIBLE? A SPANISH PILOT STUDY

Descargar Publicación
Incretin-Based Therapies in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF): A Systematic Review of Emerging Cardiometabolic Disease Modification Beyond Glycemic Contro Obesity-induced left atrial dysfunction across age groups and cardiovascular conditions: a comprehensive review of diagnostic advances and clinical implications